Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an update.
MIRA Pharmaceuticals, Inc. announces a significant leadership change as Michael Jerman resigns from the board to pursue other interests, and Matthew Pratt Whalen steps in as the new board member and Chairman of the Audit Committee. Whalen, a seasoned CPA with vast experience in public accounting and corporate finance, is expected to bring substantial expertise and strategic oversight to the company, enhancing its financial governance and growth potential.
Find detailed analytics on MIRA stock on TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
